Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Bello

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Scientific Reports|March 11, 2022
The relevance of migraine in the clinical spectrum of mitochondrial disordersAlberto Terrin, Luca Bello, Maria Lucia Valentino, et al.
Clinical Epigenetics|December 4, 2025
Histone deacetylases in Duchenne muscular dystrophy: a role in the mechanism of disease and a target for inhibitionMariarita Bertoldi, Emilio Albamonte, Luca Bello, et al.
Neuromuscular Disorders : NMD|October 29, 2021
Whole-body muscle MRI in McArdle diseaseDavid Tobaly, Pascal Laforêt, Tanya Stojkovic, et al.
Scientific Reports|September 2, 2016
Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathiesLuca Bello, Paola Campadello, Andrea Barp, et al.
Neurology|August 28, 2015
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History StudyLuca Bello, Heather Gordish-Dressman, Lauren P Morgenroth, et al.
Mass Spectrometry Reviews|November 24, 2022
Characterization of the dystrophin-associated protein complex by mass spectrometryEmily H Canessa, Rita Spathis, James S Novak, et al.
The Journal of Pathology|March 21, 2012
TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscleLuisa Piva, Bruno F Gavassini, Luca Bello, et al.
Recenti Progressi in Medicina|May 16, 2025
[Administrative healthcare data to identify and describe patients with rare diseases: the case of Duchenne muscular dystrophy.]Letizia Dondi, Giulia Ronconi, Leonardo Dondi, et al.
JAMA Neurology|March 7, 2017
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of DiseaseAlessandra Gaiani, Ilaria Martinelli, Luca Bello, et al.
Pharmaceutics|November 27, 2024
Clinical Evidence Regarding Spermidine-Hyaluronate Gel as a Novel Therapeutic Strategy in Vestibulodynia ManagementFilippo Murina, Alessandra Graziottin, Nicla Toni, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Scientific Reports|March 11, 2022
The relevance of migraine in the clinical spectrum of mitochondrial disordersAlberto Terrin, Luca Bello, Maria Lucia Valentino, et al.
Clinical Epigenetics|December 4, 2025
Histone deacetylases in Duchenne muscular dystrophy: a role in the mechanism of disease and a target for inhibitionMariarita Bertoldi, Emilio Albamonte, Luca Bello, et al.
Neuromuscular Disorders : NMD|October 29, 2021
Whole-body muscle MRI in McArdle diseaseDavid Tobaly, Pascal Laforêt, Tanya Stojkovic, et al.
Scientific Reports|September 2, 2016
Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathiesLuca Bello, Paola Campadello, Andrea Barp, et al.
Neurology|August 28, 2015
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History StudyLuca Bello, Heather Gordish-Dressman, Lauren P Morgenroth, et al.
Mass Spectrometry Reviews|November 24, 2022
Characterization of the dystrophin-associated protein complex by mass spectrometryEmily H Canessa, Rita Spathis, James S Novak, et al.
The Journal of Pathology|March 21, 2012
TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscleLuisa Piva, Bruno F Gavassini, Luca Bello, et al.
Recenti Progressi in Medicina|May 16, 2025
[Administrative healthcare data to identify and describe patients with rare diseases: the case of Duchenne muscular dystrophy.]Letizia Dondi, Giulia Ronconi, Leonardo Dondi, et al.
JAMA Neurology|March 7, 2017
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of DiseaseAlessandra Gaiani, Ilaria Martinelli, Luca Bello, et al.
Pharmaceutics|November 27, 2024
Clinical Evidence Regarding Spermidine-Hyaluronate Gel as a Novel Therapeutic Strategy in Vestibulodynia ManagementFilippo Murina, Alessandra Graziottin, Nicla Toni, et al.
Pageof 15